Bouillon R
Catholic University of Leuven, Laboratory of Experimental Medicine and Endocrinology, Belgium.
Horm Res. 1991;36 Suppl 1:49-55. doi: 10.1159/000182189.
Bone and mineral metabolism is regulated by numerous hormones and local growth factors. Growth hormone (GH), directly and/or indirectly through local IGF1 and IGF2 production, stimulates bone turnover as it increases osteoblast number and function. It also stimulates bone resorption through unknown mechanisms. GH (by IGF1) stimulates the renal 25-hydroxyvitamin D-1 alpha-hydroxylase activity and therefore enhances calcium and phosphate absorption in the intestine. It also increases the maximal renal tubular reabsorption of phosphate. The overall effect of GH on bone therefore seems beneficial as bone mass is increased together with the lean body mass. Large excess of GH, however, also increases the risk of osteoarthritis and has other serious metabolic side effects, so that its place in the treatment/prevention of osteoporosis is yet to be defined.
骨与矿物质代谢受多种激素和局部生长因子调节。生长激素(GH)通过局部产生胰岛素样生长因子1(IGF1)和胰岛素样生长因子2(IGF2)直接和/或间接刺激骨转换,因为它可增加成骨细胞数量并增强其功能。它还通过未知机制刺激骨吸收。GH(通过IGF1)刺激肾脏25-羟维生素D-1α-羟化酶活性,从而增强肠道对钙和磷的吸收。它还增加肾小管对磷的最大重吸收。因此,GH对骨的总体作用似乎是有益的,因为骨量与瘦体重同时增加。然而,GH大量过量也会增加骨关节炎风险并产生其他严重的代谢副作用,因此其在骨质疏松症治疗/预防中的地位尚待确定。